Article Versions Notes

Stanisavljevic N, Stojanovich L, Djokovic A, Todic B, Dopsaj V, Saponjski J, Saponjski D, Markovic O, Belizna C, Zdravkovic M, et al. Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. International Journal of Molecular Sciences. 2022; 23(20):12309. https://doi.org/10.3390/ijms232012309

Stanisavljevic, Natasa, Ljudmila Stojanovich, Aleksandra Djokovic, Brankica Todic, Violeta Dopsaj, Jovica Saponjski, Dusan Saponjski, Olivera Markovic, Cristina Belizna, Marija Zdravkovic, and et al. 2022. "Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients" International Journal of Molecular Sciences 23, no. 20: 12309. https://doi.org/10.3390/ijms232012309

Stanisavljevic, N., Stojanovich, L., Djokovic, A., Todic, B., Dopsaj, V., Saponjski, J., Saponjski, D., Markovic, O., Belizna, C., Zdravkovic, M., & Marisavljevic, D. (2022). Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. International Journal of Molecular Sciences, 23(20), 12309. https://doi.org/10.3390/ijms232012309